[Federal Register Volume 70, Number 69 (Tuesday, April 12, 2005)]
[Notices]
[Pages 19137-19138]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-7414]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of Bio-Heal Laboratories, Inc.; Order of Suspension 
of Trading

April 8, 2005.
    It appears to the Securities and Exchange Commission that the 
public interest and the protection of investors require a suspension of 
trading in the securities of Bio-Heal Laboratories, Inc. (``Bio-
Heal''). The Commission is concerned that Bio-Heal may have unlawfully 
issued approximately 12 million shares of common stock in purported 
reliance on Rule 504 of Regulation D of the Securities Act of 1933. 
Bio-Heal, a company that is delinquent in its periodic filing 
obligations under Section 13(a) of the Securities Exchange Act of 1934 
(``Exchange Act''), is quoted on the Pink Sheets under the ticker 
symbol BHLL.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed company.
    Therefore, it is ordered, pursuant to Section 12(k) of the Exchange 
Act, that trading in the above-listed company is suspended for the 
period from 9:30 a.m.

[[Page 19138]]

e.d.t. April 8, 2005 through 11:59 p.m. e.d.t., on April 21, 2005.

    By the Commission.
Margaret H. McFarland,
Deputy Secretary.
[FR Doc. 05-7414 Filed 4-8-05; 1:51 pm]
BILLING CODE 8010-01-P